ANTHONY C HOOPER Insider Trading $AMGN AMGEN INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ANTHONY C HOOPER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ANTHONY C HOOPER. ANTHONY C HOOPER is EVP, Global Commercial Ops. in AMGEN INC ($AMGN) and President US Pharmaceuticals in BRISTOL MYERS SQUIBB CO ($BMY) and Director in MANNKIND CORP ($MNKD) and Director in BeiGene, Ltd. ($BGNE).

Over the past year ANTHONY C HOOPER has been an insider in 2 companies. The total value of shares held by ANTHONY C HOOPER in these companies amounts to $64,363.

ANTHONY C HOOPER EVP, Global Commercial Ops.
AMGEN INC
Director
BeiGene, Ltd.
President US Pharmaceuticals
BRISTOL MYERS SQUIBB CO
Director
MANNKIND CORP
$ 64363 The total value of shares held by ANTHONY C HOOPER
Insider Rank

ANTHONY C HOOPER ranks 31,810 out of 350,000 insiders. Go to Insider Ranking to see more.

ANTHONY C HOOPER in AMGEN INC

Trading Symbol: AMGN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANTHONY C HOOPER: EVP, Global Commercial Ops.
Holdings: 215,147 shares
Current Value: $35,890,823
Latest Transaction: May 07 2018
$AMGN Market Capitalization: $124.07B
$AMGN Previous Close: $166.82

Last 4 weeks trend: STRONG BUY
Last 3 months trend: BUY

Last 3 Months Overview:
Buy: 5x
Sell: 10x
Shares Bought: 55,274
Shares Sold: 50,807
Share Difference: +4,467
Value Difference: +$8,134,915

Latest Insider Trading Transactions of ANTHONY C HOOPER in AMGEN INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMGN, BGNE, BMY, MNKD

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 07 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF169.43883149,607215,147216 K to 215.1 K (-0.41 %)
May 01 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Option ExerciseA177.4634,7026,158,21734,702
May 01 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.004,5080216,030211.5 K to 216 K (+2.13 %)
Mar 27 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF176.088,8071,550,737211,522220.3 K to 211.5 K (-4.00 %)
Mar 09 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.0017,6380220,121202.5 K to 220.1 K (+8.71 %)
Feb 01 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF191.27651124,517202,483203.1 K to 202.5 K (-0.32 %)
Feb 01 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF198.00575113,850203,134203.7 K to 203.1 K (-0.28 %)
May 03 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Option ExerciseA162.6043,5727,084,80743,572
May 03 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.004,9200203,402198.5 K to 203.4 K (+2.48 %)
Mar 28 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF166.0412,1282,013,733198,482210.6 K to 198.5 K (-5.76 %)
Mar 09 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.0023,0920210,397187.3 K to 210.4 K (+12.33 %)
Feb 02 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF154.43668103,159187,305188 K to 187.3 K (-0.36 %)
Jan 31 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF157.1659893,982187,973188.6 K to 188 K (-0.32 %)
Jan 31 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF157.161,053165,489188,571189.6 K to 188.6 K (-0.56 %)
May 05 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Option ExerciseA156.3543,5576,810,13743,557
May 05 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.005,1160189,312184.2 K to 189.3 K (+2.78 %)
Apr 29 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF162.851,659270,168184,196185.9 K to 184.2 K (-0.89 %)
Mar 29 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF149.2423,7853,549,673185,855209.6 K to 185.9 K (-11.35 %)
Mar 04 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.0045,2680209,230164 K to 209.2 K (+27.61 %)
Feb 01 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF152.7365199,427163,962164.6 K to 164 K (-0.40 %)
Feb 01 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF150.47995149,718164,339165.3 K to 164.3 K (-0.60 %)
Apr 28 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF167.911,575264,458165,334166.9 K to 165.3 K (-0.94 %)
Mar 31 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF160.5528,6244,595,583166,909195.5 K to 166.9 K (-14.64 %)
Mar 13 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF153.5827,5404,229,593195,148222.7 K to 195.1 K (-12.37 %)
Mar 06 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.00107,3540222,688115.3 K to 222.7 K (+93.08 %)
Mar 03 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF157.723,215507,070115,334118.5 K to 115.3 K (-2.71 %)

Page:   1